ASX:RSH Respiri (RSH) Stock Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free RSH Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.19 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield6.00%Price TargetN/A Stock AnalysisStock Analysis Get Respiri alerts: Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details About RespiriRespiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company is based in Melbourne, Australia.Read More Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details RSH Stock News HeadlinesApril 30, 2024 | msn.comAdherium’s focus on US market could pay off big time for its novel asthma deviceJanuary 24, 2024 | msn.comASX Health Stocks: Memphasys tumbles almost 30pc after cow pregnancy trial disappointsMay 4, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.December 14, 2023 | msn.comCheck Up: Introducing the Brain Atlas, the largest map of the human brain. And recent ASX biotech winnersNovember 17, 2023 | msn.comASX Small Caps and IPO Weekly Wrap: Goldies surge, oil spills and five Small Caps cracked a ton of gains. Amazing.August 9, 2023 | msn.comCLOSING BELL: CBA makes bank from rising rates, then issues a warning about mortgage arrearsMay 3, 2023 | finance.yahoo.comRespiri Limited (RSHUF) Stock Historical Prices & Data - Yahoo FinanceApril 13, 2023 | thestreet.comWhy RadioShack (RSH) Stock Skyrocketed TodayMay 4, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.March 3, 2023 | finance.yahoo.comRespiri First Half 2023 Earnings: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2022)February 24, 2023 | proactiveinvestors.comRespiri crosses off new milestones to deliver Wheezo to respiratory illness patients in U.S.February 20, 2023 | finance.yahoo.comRush Uranium Corp. (RSH.CN)September 25, 2022 | finanznachrichten.deRespiri (RSH): Initiation - Objective measures for better outcomesSeptember 23, 2022 | markets.businessinsider.comRespiri (RSH): Initiation Objective measures for better outcomesAugust 17, 2022 | au.finance.yahoo.comRespiri Limited (RSH.AX)August 12, 2022 | reuters.comRSH.AX - Respiri Ltd | Stock Price & Latest News | ReutersMay 26, 2022 | news.yahoo.comRecord U.S. reverse repos highlight problem of investing excess cashMay 26, 2022 | yahoo.com'Hunter x Hunter' creator announces the manga’s return after 3-year hiatusMay 24, 2022 | finance.yahoo.comIs Respiri (ASX:RSH) In A Good Position To Invest In Growth?February 4, 2022 | msn.comASX Health Stocks: PIQ leaps 9pc on blood test results; Respiri gains 6pc on Wheezo orderDecember 23, 2021 | msn.comHere’s why the Respiri (ASX:RSH) share price jumped 14% todayNovember 12, 2021 | finance.yahoo.comIs Respiri (ASX:RSH) In A Good Position To Deliver On Growth Plans?See More Headlines Receive RSH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Respiri and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:RSH CUSIPN/A CIKN/A Webwww.respiri.co Phone61 3 9602 3366FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,390,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-223.57% Return on Assets-83.20% Debt Debt-to-Equity Ratio3.31 Current Ratio1.62 Quick Ratio1.08 Sales & Book Value Annual Sales$772,196.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow37.00 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,060,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.03 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Nicholas SmedleyExecutive ChairmanMr. Marjan Mikel B.Sc.M.A.I.C.D., CEO, MD & Executive DirectorMr. Peter HildebrandtChief Operations OfficerMr. George VlachodimitropoulosChief Technology OfficerDr. Samaneh Sarraf ShiraziChief Research OfficerMr. Theo AntonopoulosChief Commercial OfficerMr. William SigsbeeHead of US Operations & Chief Commercial OfficerMr. Justin Mouchacca B.Bus (Acc)C.A., CA, Joint Company SecretaryMs. Nova Anne TaylorJoint Company SecretaryProf. Noam GavrielyMedical & Scientific AdvisorMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersNicholas SmedleySold 30,000,000 sharesTotal: $930,000.00 ($0.03/share)Brian LeedmanBought 620,068 shares on 5/30/2023Total: $22,942.52 ($0.04/share) This page (ASX:RSH) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Respiri Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
